28 Recruiting Hematologic Malignancies Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Hematologic Malignancies
Top Recruiting Hematologic Malignancies Studies
Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Hematologic Malignancies
📍 University of California, San Francisco (UCSF) — San Francisco, California
View Study & Checklist ➔Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies With Alpha Beta TCell and B Cell Depletion Using the CliniMACS Device
📍 Children's Hospital of Wisconsin — Milwaukee, Wisconsin
View Study & Checklist ➔A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔Digital Health Intervention for Self-Management and Telemonitoring in Chimeric Antigen Receptor (CAR-T) Therapy
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
📍 City of Hope National Medical Center — Duarte, California
View Study & Checklist ➔APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies
📍 Mayo Clinic — Jacksonville, Florida
View Study & Checklist ➔IVIG for Infection Prevention After CAR-T-Cell Therapy
📍 City of Hope Cancer Center — Duarte, California
View Study & Checklist ➔Prophylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic Malignancies
📍 UW Carbone Cancer Center — Madison, Wisconsin
View Study & Checklist ➔Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔Optimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Have Relapsed After First Allogeneic Stem Cell Transplantation
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
📍 Highlands Oncology Group ( Site 2728) — Springdale, Arkansas
View Study & Checklist ➔Post-Transplant Cyclophosphamide in Patients Aged >/= 65 Years Undergoing Haploidentical Transplant
📍 Cedars-Sinai Medical Center — Los Angeles, California
View Study & Checklist ➔DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics
📍 Lineberger Comphrehensive Cancer Center at University of North Carolina — Chapel Hill, North Carolina
View Study & Checklist ➔A Study to Assess the Effect of Venetoclax on Ethinyl Estradiol and Levonorgestrel in Female Participants With Different Hematological Malignancies
📍 Duplicate_Henry Ford Health System /ID# 209090 — Detroit, Michigan
View Study & Checklist ➔Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
📍 O'Neal Comprehensive Cancer Center, University of Alabama — Birmingham, Alabama
View Study & Checklist ➔